1. BAPST. A Combo of Common Use Drugs as Metabolic Therapy for Cancer: A Theoretical Proposal
   Adriana Romo-Perez et al, 2022, Current Molecular Pharmacology CrossRef
2. Metabolic Classification and Intervention Opportunities for Tumor Energy Dysfunction
   Ezequiel Monferrer et al, 2021, Metabolites CrossRef
3. Lonidamine loaded Poly(ethylene glycol)–block–poly(ε-caprolacton) nanocarriers inhibited the proliferation of colorectal cancer cells through G0/G1 cell cycle arrest
   Filiz Bakar-Ates et al, 2022, Journal of Drug Delivery Science and Technology CrossRef
4. The Crosstalk Between Signaling Pathways and Cancer Metabolism in Colorectal Cancer
   Kha Wai Hon et al, 2021, Frontiers in Pharmacology CrossRef
5. Progress in Metabolic Studies of Gastric Cancer and Therapeutic Implications
   Alfonso Duenas-Gonzalez et al, 2022, Current Cancer Drug Targets CrossRef
6. Mitochondrial remodeling in colorectal cancer initiation, progression, metastasis, and therapy: A review
   Nourhan M. Abdelmaksoud et al, 2023, Pathology - Research and Practice CrossRef
7. Metabolic Pathways Regulating Colorectal Cancer: A Potential Therapeutic Approach
   Nima Zafari et al, 2022, Current Pharmaceutical Design CrossRef
8. Metabolic Reprogramming of Colorectal Cancer Cells and the Microenvironment: Implication for Therapy
   Miljana Nenkov et al, 2021, International Journal of Molecular Sciences CrossRef
9. Hypoxia drives CBR4 down‐regulation promotes gastroenteropancreatic neuroendocrine tumors via activation mammalian target of rapamycin mediated by fatty acid synthase
   Mujie Ye et al, 2024, Journal of Cell Communication and Signaling CrossRef